MISSISSAUGA, ONTARIO--(Marketwire - Feb. 12, 2013) - CML HealthCare Inc. (TSX:CLC) (the "Company" or "CML"), a leading community-based provider of laboratory and medical imaging services in Ontario and British Columbia, today announced that it has entered into an exclusive Vendor Supply and Capital Equipment Service Agreement (the "Agreement") with Sysmex Canada, Inc. ("Sysmex"), the Canadian subsidiary of Sysmex Corporation, a global leader in clinical laboratory systemization and solutions. Under the Agreement, CML will purchase three Sysmex HST-N™ Total Hematology Automation System lines which will be fully implemented and operational by the second quarter of 2013. The Sysmex automated hematology lines will provide CML with the benefits of enhanced clinical opportunities, increased capacity, and improved operational efficiencies.
"Our decision to acquire Sysmex's automated hematology system is consistent with our stated strategy of focusing on core competencies in laboratory services. Sysmex will allow us to increase our capacity and improve efficiency while reducing our annual operating costs," said Thomas Wellner, President and CEO of CML. "In addition to its world-class technology, Sysmex is an ideal partner in providing a comprehensive set of resources and services including implementation, performance monitoring, and ongoing learning. We are proud to utilize Sysmex's advanced clinical diagnostic tools to establish leading practices at our central laboratory to help us support the delivery of quality, timely, and cost-effective healthcare to Ontarians."
"As a leading manufacturer of hematology analyzers, Sysmex is committed to advancing healthcare. We do this by taking a strong look at our customers' needs from a forward-looking perspective. Our ability to anticipate change, coupled with our long-term stability, enables us to provide hematology solutions that help clinical laboratories such as CML improve their operations in response to market demands," said Carl Rocha, General Manager, Sysmex Canada, Inc. "We trust our reliable automated hematology solutions will enable CML to achieve its goals while withstanding increasing workload demands and testing complexity of an aging population," said Rocha.
Sysmex offers reliable, scalable automation and IT solutions that provide opportunities for broad spectrum hematology laboratories to increase efficiency for laboratories of varying volumes. Sysmex's decision support software for clinical laboratory, Sysmex WAM™, complements this scale of testing by managing and standardizing clinical results across a single testing site, or as an enterprise-wide solution to connect multiple testing sites or sites with multiple systems.
About Sysmex Canada, Inc.
Sysmex Canada, Inc., a wholly-owned subsidiary of Sysmex America, Inc., is the Canadian headquarters of Sysmex Corporation (Kobe, Japan). Sysmex is a world leader in clinical laboratory systemization and solutions, including clinical diagnostics, automation and information systems. Serving customers for over 40 years, Sysmex focuses on extending the boundaries of diagnostic science while providing the management information tools that make a real difference in clinical and operational results for people worldwide. For more information about Sysmex, please visit www.sysmex.com.
About CML HealthCare Inc.
Based in Mississauga, Ontario, CML HealthCare Inc. is Canada's leading community-based, medical diagnostic services provider operating 140 laboratory collection centres in Ontario, 83 imaging centres in Ontario and British Columbia, and a reference laboratory in Ontario focused on specialized coagulation testing for customers worldwide. CML is publicly-traded on the Toronto Stock Exchange under the symbol "CLC" and has approximately 89.8 million common shares outstanding. For more information, please visit www.cmlhealthcare.com or follow CML on Twitter @cmlhealthcare.